Effects of Age and Immune Landscape on Outcome in HER2-positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2206